Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine,…
Browsing Category